SG Americas Securities’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-897
Closed -$22K 3951
2021
Q3
$22K Buy
+897
New +$27K ﹤0.01% 3777
2020
Q3
Sell
-972
Closed -$67K 3690
2020
Q2
$67K Buy
+972
New +$38.7K ﹤0.01% 3483
2020
Q1
Sell
-2,453
Closed -$38K 3755
2019
Q4
$38K Sell
2,453
-16
-0.6% -$212 ﹤0.01% 3096
2019
Q3
$27K Sell
2,469
-663
-21% -$5.9K ﹤0.01% 2885
2019
Q2
$25K Sell
3,132
-36
-1% -$366 ﹤0.01% 2980
2019
Q1
$44K Sell
3,168
-430
-12% -$4.98K ﹤0.01% 3216
2018
Q4
$29K Buy
+3,598
New +$63K ﹤0.01% 2892
2018
Q1
Sell
-4,835
Closed -$221K 3638
2017
Q4
$221K Buy
4,835
+2,958
+158% +$157K ﹤0.01% 2373
2017
Q3
$116K Buy
1,877
+636
+51% +$37.2K ﹤0.01% 3091
2017
Q2
$79K Sell
1,241
-939
-43% -$52K ﹤0.01% 2969
2017
Q1
$162K Sell
2,180
-869
-29% -$96.7K ﹤0.01% 2604
2016
Q4
$455K Buy
+3,049
New +$539K ﹤0.01% 1766

Other funds holding NH

SG Americas Securities's NH Position: Q4 2021 in Review

SG Americas Securities sold out of NantHealth, Inc (NH) in Q4 2021, closing a stake of 897 shares — an estimated $22K sold.

SG Americas Securities first reported a position in NH in Q4 2016 and held it in 12 quarters. The position peaked at $455K in Q4 2016. 43 funds tracked by Wall St. Rank hold NH as of Q4 2021.

  • SG Americas Securities reported no remaining NantHealth, Inc position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 897 NantHealth, Inc shares in Q4 2021, an estimated $22K.
  • SG Americas Securities first reported a position in NantHealth, Inc in Q4 2016 and held it in 12 quarters.
  • SG Americas Securities's NantHealth, Inc position peaked at $455K in Q4 2016.
  • 43 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.